Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1987 1
1989 1
1991 1
1992 3
2002 1
2003 1
2004 1
2005 2
2007 1
2011 3
2012 4
2013 1
2014 6
2015 8
2016 5
2017 5
2018 14
2019 5
2020 1
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pradel regard
Your search for priadel-retard retrieved no results
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park JS, Poonyagariyagorn HK, Wuyts W, Wells AU. Cottin V, et al. Eur Respir Rev. 2018 Dec 21;27(150):180076. doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578335 Free PMC article. Review.
Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodulatory therapies, decreased quality of life and, potentially, early death. Idiopathic pulmonary fibrosis may be regarded as a model for other progre …
Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodulatory therapie …
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.
Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225). Davidson SM, et al. J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086. J Am Coll Cardiol. 2019. PMID: 30621955 Free article. Review.
Many cardioprotective strategies act through common end-effectors and may be suboptimal in patients with comorbidities. In this regard, emerging data suggest that optimal cardioprotection may require the combination of additive or synergistic multitarget therapies. ...
Many cardioprotective strategies act through common end-effectors and may be suboptimal in patients with comorbidities. In this regard
Clinical Applications of Photon-counting CT: A Review of Pioneer Studies and a Glimpse into the Future.
Douek PC, Boccalini S, Oei EHG, Cormode DP, Pourmorteza A, Boussel L, Si-Mohamed SA, Budde RPJ. Douek PC, et al. Radiology. 2023 Oct;309(1):e222432. doi: 10.1148/radiol.222432. Radiology. 2023. PMID: 37787672 Review.
In addition, multiple types of information can be extracted from a single data set (ie, multiparametric imaging), including quantitative data often regarded as surrogates of functional information (eg, lung perfusion). ...
In addition, multiple types of information can be extracted from a single data set (ie, multiparametric imaging), including quantitative dat …
Veno-venous extracorporeal membrane oxygenation: cannulation techniques.
Banfi C, Pozzi M, Siegenthaler N, Brunner ME, Tassaux D, Obadia JF, Bendjelid K, Giraud R. Banfi C, et al. J Thorac Dis. 2016 Dec;8(12):3762-3773. doi: 10.21037/jtd.2016.12.88. J Thorac Dis. 2016. PMID: 28149575 Free PMC article. Review.
Current ECMO therapies provide a variety of options for the multidisciplinary teams who are involved in the management of these critically ill patients. In this regard, veno-venous ECMO (VV-ECMO) can provide quite complete respiratory support, even if this highly complex t …
Current ECMO therapies provide a variety of options for the multidisciplinary teams who are involved in the management of these critically i …
The impact of human complement on the clinical outcome of malaria infection.
Reiss T, Müller F, Pradel G. Reiss T, et al. Mol Immunol. 2022 Nov;151:19-28. doi: 10.1016/j.molimm.2022.08.017. Epub 2022 Sep 2. Mol Immunol. 2022. PMID: 36063583 Free article. Review.
We discuss the various types of interactions between malaria parasites and complement factors with regard to immunity and infection outcome and set a special emphasis on the dual role of complement in the context of parasite fitness....
We discuss the various types of interactions between malaria parasites and complement factors with regard to immunity and infection o …
Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
Harari S, Spagnolo P, Cocconcelli E, Luisi F, Cottin V. Harari S, et al. Curr Opin Pulm Med. 2018 Sep;24(5):469-476. doi: 10.1097/MCP.0000000000000502. Curr Opin Pulm Med. 2018. PMID: 29927757 Review.
Accordingly, recent guidelines issued by the American Thoracic Society and the Japanese Respiratory Society recommend sirolimus treatment for patients with LAM and reduced lung function. Uncertainty remains, however, with regard to patient selection, and timing of initiati …
Accordingly, recent guidelines issued by the American Thoracic Society and the Japanese Respiratory Society recommend sirolimus treatment fo …
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis.
Cottin V. Cottin V. Respir Res. 2013;14 Suppl 1(Suppl 1):S5. doi: 10.1186/1465-9921-14-S1-S5. Epub 2013 Apr 16. Respir Res. 2013. PMID: 23734908 Free PMC article. Review.
Evidence of beneficial effects of pirfenidone treatment was also observed with regard to several secondary endpoints. Pirfenidone was generally well tolerated, with the most common side effects being gastrointestinal and photosensitivity. ...
Evidence of beneficial effects of pirfenidone treatment was also observed with regard to several secondary endpoints. Pirfenidone was …
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, McNitt-Gray M, Maher TM. Khanna D, et al. J Scleroderma Relat Disord. 2022 Oct;7(3):168-178. doi: 10.1177/23971983211064463. Epub 2022 Jan 3. J Scleroderma Relat Disord. 2022. PMID: 36211204 Free PMC article. Review.
In addition to being an important screening and diagnostic tool, high-resolution computed tomography can be used to evaluate disease extent in systemic sclerosis-associated interstitial lung disease and may be helpful in assessing prognosis in some patients. Currently, there is n …
In addition to being an important screening and diagnostic tool, high-resolution computed tomography can be used to evaluate disease extent …
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes.
Cottin V. Cottin V. Eur Respir Rev. 2012 Jun 1;21(124):161-7. doi: 10.1183/09059180.00001112. Eur Respir Rev. 2012. PMID: 22654089 Free PMC article. Review.
Evidence of beneficial effects of pirfenidone treatment was also observed with regard to several secondary end-points, including progression-free survival time, categorical FVC change, and mean change from baseline to week 72 in 6MWT distance. ...
Evidence of beneficial effects of pirfenidone treatment was also observed with regard to several secondary end-points, including prog …
67 results